MPWT
OTLK icon

MassMutual Private Wealth & Trust’s Outlook Therapeutics OTLK Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-767
Closed -$936 – 2460
2025
Q1 		$936 Buy
+767
New +$1.34K ﹤0.01% 2143

Other funds holding OTLK

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MassMutual Private Wealth & Trust's OTLK Position: Q2 2025 in Review

MassMutual Private Wealth & Trust sold out of Outlook Therapeutics (OTLK) in Q2 2025, closing a stake of 767 shares — an estimated $936 sold.

MassMutual Private Wealth & Trust first reported a position in OTLK in Q1 2025 and held it in 1 quarter. The position peaked at $936 in Q1 2025. 66 funds tracked by Wall St. Rank hold OTLK as of Q2 2025.

  • MassMutual Private Wealth & Trust reported no remaining Outlook Therapeutics position as of Q2 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 767 Outlook Therapeutics shares in Q2 2025, an estimated $936.
  • MassMutual Private Wealth & Trust first reported a position in Outlook Therapeutics in Q1 2025 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Outlook Therapeutics position peaked at $936 in Q1 2025.
  • 66 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2025, filed 9 Jul 2025.